Zhou, Grace C.
Wang, Ziyun
Palipana, Anushka K.
Andrinopoulou, Eleni-Rosalina
Miranda Afonso, Pedro
McPhail, Gary L.
Siracusa, Christopher M.
Gecili, Emrah
Szczesniak, Rhonda D.
Funding for this research was provided by:
National Heart, Lung and Blood Institute (R01HL141286)
Cystic Fibrosis Foundation (003990322, 005412A123)
Article History
Received: 15 February 2024
Accepted: 28 March 2024
First Online: 27 April 2024
Declarations
:
: This study was approved by the Cincinnati Children’s Hospital Medical Center’s Institutional Review Board (Study ID: 2018–3912) and approved by the Cystic Fibrosis Foundation Patient Registry (CFFPR) Committee. The CFFPR collects information on the health status of people with cystic fibrosis who receive care in Cystic Fibrosis Foundation-accredited care centers and agree to participate in the CFFPR.
: To contribute data to the CFFPR, each Registry participant or their legal guardian completes an informed consent through their CF Foundation accredited care center. All experiments were performed in accordance with the CCHMC Human Research Program within the Office of Research Compliance and Regulatory Affairs and CF Foundation information use agreement terms.
: Not applicable.
: The authors declare no conflict of interest in relation to this manuscript.